Søgning på udtrykket 'covid' giver 83 resultater
Dokumenter [10] Sider [3] Kalender [29] Nyt fra tidsskrifterne [+20] Aktuelle smitsomme sygdomme [+20]
Dokumenter [10]
Ændringer siden version 28: Moderat risikogruppe udgår. Gravide udgår som risikogruppe. Skærpelse af kriterier for opstart af Paxlovid (nu kun højrisiko patient med indikation).
Dette notat omfatter patienter med følger efter infektion med SARS-CoV-2. Aktuelt defineres vedvarende symptomer ≥4 uger efter infektionsstart som langvarige symptomer, og vedvarende symptomer ≥12 uger anses som senfølger efter COVID-19.
Invitation til møde den 20. maj 2022
Ændringer siden sidste udgave: 1. Simplificering af risikogrupper. 2. Skærpelse af kriterier for opstart af behandling hos indlagte patienter, f.eks. blodgas analyse før remdesivir. 3. Information om høj pris på paxlovid og højere NNT for beskyttelse mod alvorligt forløb siden primærpublikation.
COVID-19 pandemien: Erfaringer vedrørende migranter og etniske minoriteters sundhed
Virtuelt årsmøde med fokus på COVID-19 den 7. maj 2021
DSI anbefaler fortsat remdesivir ved indlæggelsekrævende COVID-19 med behov for tilskud af ilt, hvor iltmætningen i blodet er under 94% uden ilttilskud hos ellers lungeraske og, at hvor der ved røntgen af thorax påvises infiltrat(er). Dette holdningspapir omhandler baggrunden for anbefalingen.
Indlæg af formand Rikke Krogh-Madsen i Altinget om opgradering af det infektionsmedicinske speciale
Vurdering af behov for antivirale midler og effekt af SARS-CoV2 infektion i de risikogrupper, som ifølge gældende retningslinjer skal tilbydes behandling med lægemidlet.
Afholdt fredag den 25. september 2020 som onlinemøde med fokus på COVID-19
Sider [3]
… Borrelia: Anne-Mette Lebech (tovholder), Christian Brandt, Fredrikke Christie Knudtzen, Helene Mens, Jacob Bodilsen, Sigurdur Skarphédinsson Borrelia klaringsrapport (2014), Diagnostik og behandling af Lyme neuroborreliose (2021), COVID-19: Behandling af COVID-19: Michael Dalager-Pedersen (tovholder), Marie Helleberg, Gitte Kronborg, Isik Somuncu, Merete Storgaard, Lothar Wiese COVID-19 retningslinje (2024v28), Post-COVID-19: Jacob Bodilsen, Christian Brandt, Stine Jo…
…diagnostiske undersøgelser ikke forsinke empirisk behandling ved symptomer herpå. Vaccinationer: Primær vaccination foretages mod Streptococcus pneumoniae, Haemophilus influenzae type B og Neisseria meningitidis. Årlig influenza-vaccination (samt COVID-19 vaccination ud fra aktuelle rekommandationer) anbefales på grund af øget risiko for sekundær bakteriel infektion. Pneumokokker. Den 20-valent konjugerede pneumokok vaccine, PCV20 (Apexxnar), anbefales til voksne. Apexxnar er en…
Professor Henrik Nielsen kommenterer: Så kom den endelig. Længe ventet, med spænding imødeset. Fagfællebedømt artikel om BioNTech/Pfizers BNT162b2 mRNA vaccine mod COVID-19. Selvfølgelig i NEJM og naturligvis af stor aktuel interesse, men vil også blive stående som en klassiker i medicinsk litteratur. En milepæl i vaccinologiens historie, blandt andet fordi der er anvendt en ny teknologisk platform og fordi studiet er kommet i mål på rekordtid. Alle infektionsmedicinere bør kende denne publikat…
Kalender [29]
16. januar 2023, Online
14. december 2022, Online
11. oktober 2022, Online
20. maj 2022, Aarhus Universitet
21. marts 2022, Aarhus Universitetshospital, Skejby
9. februar 2022, Online
4. januar 2022, Online
7. december 2021, Online
4. november 2021, Online
23. september 2021, Aarhus
21. september 2021, Online
31. august 2021, Holst Auditoriet, Mærsk Tårnet, København
16. juni 2021, Online
27. maj 2021, Online
7. maj 2021, Online
13. april 2021, Online
23. marts 2021, Online
22. marts 2021, Online
16. marts 2021, Online
3. februar 2021, Online
28. januar 2021, Online
19. januar 2021, Online
30. december 2020, Online
9. oktober 2020, Århus og online
25. september 2020, Online
28. juni 2020, Online
18. juni 2020, Aflyst på grund af COVID-19
3. juni 2020, Mødet udskudt på grund af COVID-19
24. marts 2020, København
Nyt fra tidsskrifterne [+20]
Der er mere end 20 resultater, måske du vil se flere resultater her?PLoS One Infectious Diseases
14.09.2024
by Zhongyang He, Jonathan M. Heess, Travis Young, Zhen Lei . The COVID-19 pandemic introduced imminent and lasting impacts on the opioid crisis in the U.S., including a significant increase in opioid overdose and deaths and in use of telehealth in treatment. What lessons can we learn from the treatment transition during the pandemic that could help tackle the opioid crisis when future pandemics strike? In this paper, we conducted a phone survey with opioid treatment facilities in Pennsylvania to examine th…
BMC Infectious Diseases
14.09.2024
. Abstract. . Objective. The persistent symptoms arising from COVID-19 infection pose a substantial threat to patients’ health, carrying significant implications. Amidst the evolving COVID-19 control strategies in China, healthcare workers (HCWs) endure considerable stress. This study aims to evaluate the prevalence of long COVID infections and their influencing factors among primary HCWs after epidemic control policy adju…
BMC Infectious Diseases
14.09.2024
. Abstract. . Background. Nirmatrelvir/ritonavir (NM/r) is a safe and effective oral antiviral therapeutic used for treatment of mild-to-moderate COVID-19. Case reports described a clinical rebound syndrome whereby individuals experience a relapse of symptoms shortly after completing successful treatment. There is a lack of information on frequency of COVID-19 rebound after NM/r in routine clinical care, contributing factors…
Infection
13.09.2024
. Abstract. . Purpose. Respiratory syncytial virus (RSV) infection is a major cause of childhood hospitalization. The COVID-19 pandemic has disrupted the usual seasonal pattern of RSV, resulting in high activity during the off-season. This study aims to evaluate the effects of the pandemic on the severity of RSV infections. . . . Methods. Data from 11,915 c…
BMJ Open
13.09.2024
. Introduction. Post-COVID-19 condition (post COVID, also known as long COVID) is a global public health issue estimated to affect over 100 million people. Common symptoms include fatigue, dyspnoea and cognitive dysfunction (‘brain fog’). Over time, these symptoms have an adverse effect on mental health, physical activity and quality of life (QoL). The condition requires innovative and feasible treatment approaches that can be effective and self-managed. Physical activity is essential for good health; h…
BMC Infectious Diseases
13.09.2024
. Abstract. . Background. Hybrid immunity provides better protection against COVID-19 than vaccination or prior natural infection alone. It induces high magnitude and broadly cross-reactive neutralising anti-Spike IgG antibodies. However, it is not clear how long these potent antibodies last, especially in the context of adenovirus-based COVID-19 vaccines. . . . …
BMC Infectious Diseases
13.09.2024
. Abstract. . Background. Antiviral drugs show significant efficacy in non-severe COVID-19 cases, yet there remains a subset of moderate COVID-19 patients whose pneumonia continues to progress post a complete course of treatment. Plasma-activated water (PAW) possesses anti-SARS-CoV-2 properties. To explore the potential of PAW in improving pneumonia in COVID-19 patients following antiviral treatment failure, we conducted thi…
New England Journal of Medicine
12.09.2024
New England Journal of Medicine, Volume 391, Issue 10, September 12, 2024.
Infection
12.09.2024
. Abstract. . Purpose. Respiratory syncytial virus (RSV) infection is a major cause of childhood hospitalization. The COVID-19 pandemic has disrupted the usual seasonal pattern of RSV, resulting in high activity during the off-season. This study aims to evaluate the effects of the pandemic on the severity of RSV infections. . . . Methods. Data from 11,915 c…
BMJ Open
12.09.2024
. Objective. Liver function test (LFT) abnormalities are higher in patients with severe COVID-19. Most of the studies on this theme were conducted in foreign nations, and the association with LFT abnormalities was not sufficiently addressed in the study areas. Therefore, the current study aimed to investigate the effects of COVID-19 infection on liver function of patients. . Setting. A facility-based comparative cross-sectional study was carried out from 10 April to 15 June 2022, among COVID-19 infected in…
Predictors of older adults health behaviours to prevent COVID-19 transmission: a multilevel analysis
BMJ Open
12.09.2024
. Objectives. While older adults showed higher mortality during COVID-19 pandemic, protective behaviours (knowledge regarding coping with COVID-19 symptoms and preventive behaviours) were highlighted to be important to prevent the spread of infection. This study aimed to identify individual and community-level variables influencing deficient knowledge regarding coping with COVID-19 and not-practicing COVID-19 of older adults during the pandemic. . Design. This is a secondary analysis of a cross-sectional s…
BMJ Open
12.09.2024
. Objectives. To appraise the quality of clinical practice guidelines (CPGs) and expert consensus statements on rehabilitation for patients with COVID-19, summarise recommendations of rehabilitation assessments and interventions and evaluate the heterogeneity of the recommendations. . Design. Systematic review. . Data sources. PubMed and Embase databases and five online guideline repositories: The National Guideline Clearinghouse, Guidelines International Network, Scottish Intercollegiate Guidelines Netwo…
BMJ Open
12.09.2024
…This study addressed two research questions: What factors do doctors in training describe as influencing their choices to apply (or not apply) for specialty training during their Foundation Year 2? Which of these factors are specific to the context of the COVID-19 pandemic, and the unique experiences of the cohort of doctors who qualified early during the pandemic? . Design. Sequential explanatory mixed methods study: Quantitative survey. Qualitative semistructured interviews. Quantitative data were analys…
BMJ Open
12.09.2024
. Objectives. This study aims to describe the incidence, symptom clusters and determinants of post-acute COVID symptoms using data from the COVID RADAR app in the Netherlands. . Design. Prospective cohort. . Setting. General population in the Netherlands from April 2020 to February 2022. . Participants. A total of 1478 COVID RADAR app users, with data spanning 40 days before to 100 days after positive SARS-CoV-2 test. . Outcome measures. Incidence and duration of 10 new symptoms that developed during ac…
BMC Infectious Diseases
12.09.2024
BMC Infectious Diseases
12.09.2024
… Background. Hospitals should prepare for emerging diseases and protect healthcare workers (HCWs) from work-related infection. This study aims to assess public hospital preparedness for the coronavirus disease 2019 (COVID-19) a year after the Myanmar government began implementing COVID-19 prevention measures, and to identify factors associated with work-related COVID-19 infection among HCWs in Myanmar. . . . …
PLoS One Infectious Diseases
11.09.2024
by Karen Jennings, Martina Lembani, Anneke C. Hesseling, Nyameka Mbula, Erika Mohr-Holland, Vanessa Mudaly, Mariette Smith, Muhammad Osman, Sue-Ann Meehan . Background Coronavirus disease (COVID-19) negatively impacted tuberculosis (TB) programs which were already struggling to meet End-TB targets globally. We aimed to quantify and compare diagnosis, treatment initiation, treatment success, and losses along this TB care cascade for drug-susceptible TB in Cape Town, South Africa, prior to and during COVID-1…
PLoS One Infectious Diseases
11.09.2024
…asoppakarn, Narumol Atthakul, Sissades Tongsima, Chantisa Keeratipusana, Watcharapot Janpoung, Virasakdi Chongsuvivatwong . Aims This study aims to compare the trends in the quality of hospital care for WHO’s three disease groups pre-, during, and post-COVID-19 pandemic peak in Thailand. Methods The study utilized existing hospital admission data from the Thai Health Information Portal (THIP) database, covering the period from 2017 to 2022. We categorized WHO’s three disease groups: poverty-related, n…
Journal of Infectious Diseases
11.09.2024
Abstract . Background . Understanding antibody responses to SARS-CoV-2 vaccination is crucial for refining COVID-19 immunization strategies. Generation of mucosal immune responses, including mucosal IgA, could be of potential benefit to vaccine efficacy, yet limited evidence exists regarding the production of mucosal antibodies following the administration of current mRNA vaccines to young children.Methods . We measured the levels of antibodies against SARS-CoV-2 from a cohort of children under 5 years of a…
Journal of the American Medical Association
11.09.2024
While the incidence of persistent and recurring symptoms of SARS-CoV-2, also known as post–COVID-19 condition or long COVID, decreased over the course of the COVID-19 pandemic, the risk remained even among those who were vaccinated, according to a new study published in the New England Journal of Medicine.
Aktuelle smitsomme sygdomme [+20]
Der er mere end 20 resultater, måske du vil se flere resultater her?Eurosurveillance latest updates
13.09.2024
. Background. Long-term effectiveness data on bivalent COVID-19 boosters are limited. . . Aim. We evaluated the long-term protection of bivalent boosters against severe COVID-19 among ≥ 65-year-olds in Finland. . . Methods. In this register-based cohort analysis, we compared the risk of three severe COVID-19 outcomes among ≥ 65-year-olds who received a bivalent booster (Original/Omicron BA.1 or Original/BA.4–5; exposed group) between 1/9/2022 and 31/8/2023 to those who did not (unexposed).…
Morbidity and Mortality Weekly Report (MMWR)
11.09.2024
This report describes the Advisory Committee on Immunization Practices' recommendations for the 2024-25 COVID-19 vaccines.
Medscape Infectious Diseases
11.09.2024
Pfizer and Moderna mRNA vaccines are updated to better match currently circulating COVID strains, while the Novavax adjuvant will target the JN.1 variant — a predecessor of KP.2. . Medscape Medical News
Medscape Infectious Diseases
7.09.2024
Help patients overcome COVID booster fatigue and update their protection against the now endemic COVID virus. . Medscape Internal Medicine
Eurosurveillance latest updates
30.08.2024
. Background. COVID-19 remains a major infectious disease with substantial implications for individual and public health including the risk of a post-infection syndrome, long COVID. The continuous changes in dominant variants of SARS-CoV-2 necessitate a careful study of the effect of preventative strategies. . . Aim. We aimed to estimate the effectiveness of post-vaccination, post-infection and hybrid immunity against severe cases requiring oxygen support caused by infections with SARS-CoV-2 variants BA1…
Medscape Infectious Diseases
28.08.2024
The program's end will leave the Canadian province without a valuable tool for monitoring infectious disease. . Medscape Medical News
Medscape Infectious Diseases
27.08.2024
Dr F. Perry Wilson comments on a study weighing the outcomes of COVID infection-associated vs COVID mRNA vaccine-associated myocarditis. . Medscape
Medscape Infectious Diseases
23.08.2024
A large study shows higher rates of depression and mental illness up to a year after COVID-19, especially severe cases of the infection, in unvaccinated adults. . Medscape Medical News
Medscape Infectious Diseases
23.08.2024
COVID-19 vaccination was not associated with increased risk for multiple sclerosis relapse, except in those with high MS activity. . Medscape Medical News
Eurosurveillance latest updates
23.08.2024
. Background. Vaccine uptake differs between social groups. Mobile vaccination units (MV-units) were deployed in the Netherlands by municipal health services in neighbourhoods with low uptake of COVID-19 vaccines. . . Aim. We aimed to evaluate the impact of MV-units on vaccine uptake in neighbourhoods with low vaccine uptake. . . Methods. We used the Dutch national-level registry of COVID-19 vaccinations (CIMS) and MV-unit deployment registrations containing observations in 253 neighbourhoods where MV…
Medscape Infectious Diseases
20.08.2024
More than half of US states are reporting signs that COVID levels are poised to continue their summerlong rise. . WebMD Health News
Medscape Infectious Diseases
15.08.2024
Long COVID rates in pregnant women are higher than previously thought and symptoms harder to treat, making motherhood more difficult and putting the child at risk. . Medscape Medical News
Eurosurveillance latest updates
9.08.2024
. Background. A new respiratory virus surveillance platform, based on nationwide hospital laboratory data, was established in Israel during the COVID-19 pandemic. . . Aim. We aimed to evaluate the performance of this platform with respect to the detection of influenza and respiratory syncytial virus (RSV) from week 36 in 2020 to week 15 in 2023, and how it fits with the World Health Organization (WHO) mosaic surveillance framework. . . Methods. Data of respiratory samples from hospitalised patients se…
Statens Serum Institut
8.08.2024
Ny undersøgelse fra WHO/Europa bekræfter den livsreddende effekt af covid-19-vacciner. Statens Serum Institut (SSI) har bidraget til undersøgelsen, som er relevant i en tid med flere årlige smittebølger.
Medscape Infectious Diseases
29.07.2024
With no standard approved long COVID therapies, research turns to a proven COVID drug and other 'low-risk, high-reward' help. . Medscape Medical News
Medscape Infectious Diseases
20.07.2024
Your chances of developing long COVID have significantly decreased since the pandemic began, according to a new study published in the New England Journal of Medicine. . WebMD Health News
Eurosurveillance latest updates
20.07.2024
. Background. The COVID-19 pandemic and the emergence of Candida auris have changed the epidemiological landscape of candidaemia worldwide. . . Aim. We compared the epidemiological trends of candidaemia in a Greek tertiary academic hospital before (2009–2018) and during the early COVID-19 (2020–2021) and late COVID-19/early post-pandemic (2022–2023) era. . . Methods. Incidence rates, species distribution, antifungal susceptibility profile and antifungal consumption were recorded, and one-way ANO…
Medscape Infectious Diseases
18.07.2024
Recent evidence suggests long COVID is primarily an autonomic nervous system disorder. But the devil is in the details. . Medscape Medical News
Medscape Infectious Diseases
16.07.2024
Remote clinical trials may be the key to recruiting more long COVID sufferers — and expediting new inroads to treatment. . Medscape Medical News
Medscape Infectious Diseases
13.07.2024
Some dairy farmers are resisting Michigan's nation-leading efforts to stop the spread of bird flu for fear their incomes will suffer from added costs and hurt rural. . Reuters Health Information